Drug

Abrocitinib

83 flagged reaction(s) · 2,956 total co-reports · max PRR 18.8

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Dermatitis Atopic	171	18.8	19.6	signal
2	Therapeutic Product Effect Incomplete	207	16.0	16.9	signal
3	Eczema	91	9.9	10.1	signal
4	Oral Herpes	32	9.0	9.1	signal
5	Folliculitis	15	7.9	8.0	signal
6	Sleep Disorder Due To A General Medical Condition	22	7.4	7.5	signal
7	Skin Fissures	25	7.2	7.3	signal
8	Tuberculosis	17	7.2	7.3	signal
9	Drug Effect Less Than Expected	18	7.0	7.0	signal
10	Therapeutic Response Unexpected	56	6.8	6.9	signal
11	Condition Aggravated	363	6.6	7.2	signal
12	Conjunctivitis	22	6.5	6.6	signal
13	Blood Triglycerides Increased	21	6.5	6.5	signal
14	Product Prescribing Error	28	6.5	6.5	signal
15	Acne	88	6.3	6.4	signal
16	Skin Haemorrhage	16	6.1	6.1	signal
17	Skin Infection	12	5.9	5.9	signal
18	Skin Disorder	35	5.7	5.8	signal
19	Blood Cholesterol Increased	47	5.5	5.6	signal
20	Liver Function Test Increased	21	5.4	5.4	signal
21	Blood Creatine Phosphokinase Increased	28	5.2	5.3	signal
22	Squamous Cell Carcinoma	9	5.2	5.2	signal
23	Drug Effective For Unapproved Indication	27	5.0	5.1	signal
24	Herpes Zoster	53	5.0	5.1	signal
25	Product Dose Omission In Error	24	4.9	4.9	signal
26	Scratch	9	4.7	4.8	signal
27	Dermatitis	17	4.5	4.5	signal
28	Sleep Disorder	55	4.3	4.3	signal
29	Lymphoma	12	4.2	4.2	signal
30	Blood Test Abnormal	10	3.9	3.9	signal
31	Skin Exfoliation	59	3.9	3.9	signal
32	Scab	8	3.9	3.9	signal
33	Skin Lesion	19	3.8	3.8	signal
34	Drug Ineffective For Unapproved Indication	38	3.7	3.8	signal
35	Rash Erythematous	31	3.6	3.6	signal
36	Spinal Operation	8	3.6	3.6	signal
37	Retinal Detachment	6	3.6	3.6	signal
38	Pruritus	238	3.4	3.6	signal
39	Therapeutic Product Effect Decreased	27	3.3	3.3	signal
40	Neutrophil Count Increased	6	3.2	3.2	signal
41	Illness	56	3.0	3.1	signal
42	Impaired Quality Of Life	8	3.0	3.0	signal
43	Pharyngitis Streptococcal	6	3.0	3.0	signal
44	Eye Disorder	18	3.0	3.0	signal
45	Appendicitis	5	2.9	2.9	signal
46	Eye Infection	6	2.9	2.9	signal
47	Immune System Disorder	7	2.9	2.9	signal
48	Blood Iron Decreased	6	2.8	2.8	signal
49	Intentional Product Misuse	43	2.7	2.7	signal
50	Dry Skin	59	2.4	2.5	signal
51	Hypoacusis	19	2.4	2.4	signal
52	Blood Lactate Dehydrogenase Increased	7	2.4	2.4	signal
53	Eye Swelling	16	2.4	2.4	signal
54	Autoimmune Disorder	4	2.3	2.3	no signal
55	Skin Cancer	9	2.3	2.3	signal
56	Drug Ineffective	529	2.2	2.4	signal
57	Rash Papular	9	2.2	2.2	signal
58	Pneumocystis Jirovecii Pneumonia	4	2.2	2.2	no signal
59	Eye Discharge	4	2.1	2.1	no signal
60	Pain Of Skin	10	2.0	2.0	signal
61	Pulmonary Thrombosis	4	2.0	2.0	no signal
62	Intentional Dose Omission	10	2.0	2.0	no signal
63	Glaucoma	7	2.0	2.0	no signal
64	Aphonia	5	2.0	2.0	no signal
65	Product Prescribing Issue	7	1.9	1.9	no signal
66	Erythema Multiforme	3	1.8	1.8	no signal
67	Eye Inflammation	3	1.7	1.7	no signal
68	Intraocular Pressure Increased	4	1.7	1.7	no signal
69	Eye Pruritus	10	1.7	1.7	no signal
70	Amenorrhoea	5	1.6	1.6	no signal
71	Malignant Melanoma	4	1.6	1.6	no signal
72	Lymphopenia	4	1.6	1.6	no signal
73	Product Dispensing Error	6	1.5	1.5	no signal
74	Cholecystectomy	3	1.4	1.4	no signal
75	Therapeutic Response Shortened	8	1.4	1.4	no signal
76	Thyroid Cancer	3	1.4	1.4	no signal
77	Skin Burning Sensation	17	1.3	1.3	no signal
78	Menstruation Irregular	6	1.2	1.2	no signal
79	Breast Cancer Female	6	1.2	1.2	no signal
80	Skin Irritation	10	1.2	1.2	no signal
81	Gastric Cancer	5	1.1	1.1	no signal
82	Circumstance Or Information Capable Of Leading To Medication Error	4	0.7	0.7	no signal
83	Prostate Cancer	6	0.4	0.4	no signal